Who We Are

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics and growing capabilities in the area of data-driven medical insights help Roche deliver truly personalized healthcare. Roche is working with partners across the healthcare sector to provide the best care for each person.

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology, and central nervous system diseases. Roche is also the world leader in in-vitro diagnostics and tissue-based cancer diagnostics and a frontrunner in diabetes management. Roche has invested in genomic profiling and real-world data partnerships in recent years and has become an industry-leading partner for medical insights. 

Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and contribute to society. The company also aims to improve patient access to medical innovations by working with relevant stakeholders. More than thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Moreover, for the twelfth consecutive year, Roche has been recognized as one of the most sustainable companies in the Pharmaceuticals Industry by the Dow Jones Sustainability Indices (DJSI).